I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
About
Anti-Money Laundering (AML) Compliance in Life Sciences training provides comprehensive knowledge of managing financial-crime risks within pharmaceutical, biotechnology, medical device, and healthcare organisations. The course covers money laundering concepts, AML regulations, sanctions compliance, risk-based approaches, customer and counterparty due diligence, beneficial ownership, politically exposed persons (PEPs), suspicious activity reporting, and financial-crime controls.
This Anti-Money Laundering Compliance in Life Sciences Training Course & Certification provides practical understanding of applying AML principles in life-sciences environments, including managing third-party risks, distributor and agent relationships, international transactions, tender processes, trade-based money laundering risks, sanctions screening, governance frameworks, and compliance monitoring. The course supports organisations in developing proportionate, risk-based financial-crime programmes aligned with regulatory expectations and industry best practices.
- Compliance and Ethics Professionals
- Quality Assurance and Regulatory Affairs Professionals
- Legal and Risk Management Teams
- Finance and Procurement Professionals
- Commercial and Business Development Teams
- Third-Party Management and Due Diligence Specialists
- Internal Audit and Governance Professionals
- Anyone involved in managing financial-crime, sanctions, and compliance risks within life-sciences organisations
What you will learn
Understand the fundamentals of Anti-Money Laundering (AML) compliance, including money laundering risks, financial crime concepts, predicate offences, and the three stages of money laundering.
Learn global AML and sanctions expectations, including FATF standards, UK and EU AML frameworks, beneficial ownership requirements, customer due diligence (CDD), and enhanced due diligence (EDD).
Gain practical knowledge of financial-crime risks specific to life sciences, including third-party risks, healthcare intermediaries, distributors, agents, tender processes, PEP exposure, sanctions, and trade-based money laundering indicators.
Understand how to implement an effective AML compliance programme, including risk assessments, governance, policies and procedures, reporting obligations, investigations, documentation, monitoring, assurance, and continuous improvement.
Course Syllabus
- Money laundering defined; placement, layering, integration
- Predicate offences; terrorist and proliferation financing
- Typologies and trade-based money laundering
- Why distributors, agents and complex payments expose life sciences
- The harm of financial crime
- Money laundering versus adjacent crimes
- Knowledge Check
- FATF standards and the risk-based approach; the grey and black lists
- UK POCA offences (everyone) and the MLR 2017 relevant-person test
- UK ECCTA and the NCA
- EU 2024 AML package, AMLR and AMLA
- US BSA, FinCEN CDD and the Corporate Transparency Act BOI position
- Determining your legal status; primary law versus guidance
- Knowledge Check
- The risk-based approach in practice
- CDD, simplified and enhanced due diligence
- Identifying and verifying counterparties
- Beneficial ownership and why thresholds differ
- PEPs on a risk basis
- Third-party, distributor and agent due diligence; proportionality
- Knowledge Check
- Complex international and third-party payments
- Trade-based money-laundering indicators
- High-value deals and tenders
- UK, EU and US sanctions; OFSI, OTSI and OFAC
- Screening, ownership-and-control and the 50% rule
- Life-sciences red flags; donations and HCP payments
- Knowledge Check
- The enterprise-wide risk assessment
- Governance, roles and the conditional MLRO
- Three lines of defence
- Proportionate policies and controls
- Third-party lifecycle; training and culture
- Monitoring, assurance and improvement
- Knowledge Check
- Recognising concerns and internal escalation
- Preserving evidence and avoiding tipping off
- The reporting decision tree
- SAR and DAML where legally applicable
- Sanctions reporting to OFSI
- Record-keeping, cooperation and improvement
- Knowledge Check
- The whole pathway on one page
- The A/B/C/D guardrails to remember
- A consolidated red-flag aide-memoire
- Applying it proportionately in your organisation
- 📘 Bonus:Anti-Money Laundering Compliance in Life Sciences eBook (Free with purchase)
Course Benefits

Get our exclusive eBook with every purchase - a complete companion guide to the course, yours to keep forever
Gain Continuing Professional Development (CPD) Points, accredited by The Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom. These can be used to count towards the distance learning element of any scheme that comes under the umbrella of The Academy of Medical Royal Colleges or any other scheme for which there is mutual recognition.
Receive a personal certificate to show your subject knowledge on course completion.
You get excellent value through our cost-effective prices. We can also offer you group discounts on larger purchases.
The course saves you time through the convenience of online availability. This lets you complete the interactive course at your own comfort.
You will stay up to date with changes to the FATF standards and lists, UK POCA and the Money Laundering Regulations, the EU AML package and AMLA, and US requirements, as our training courses are constantly monitored, reviewed and updated.
The course reflects current financial-crime practice for life-sciences organisations, so learners can apply proportionate, risk-based controls in their own organisation.






